Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: Relationship to the ovarian follicle excess and to the follicular arrest

被引:509
|
作者
Pigny, P
Merlen, E
Robert, Y
Cortet-Rudelli, C
Decanter, C
Jonard, S
Dewailly, D
机构
[1] CHRU, Hop Jeanne Flandre, Dept Endocrine Gynaecol & Reprod Med, F-59037 Lille, France
[2] CHRU, Clin Marc Linquette, Lab Endocrinol, F-59037 Lille, France
[3] CHRU, Hop Jeanne Flandre, Dept Radiol, F-59037 Lille, France
[4] CHRU, Dept Diabetol & Endocrinol, F-59037 Lille, France
来源
关键词
D O I
10.1210/jc.2003-030727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The serum level of anti-Mullerian hormone (AMH), a product from granulosa cells involved in follicle growth, has been shown to correlate tightly with the small antral follicle number (FN) at ultrasonography (U/S) in women who do not have polycystic ovary syndrome ( PCOS). Because PCOS is associated with a 2- to 3-fold increase in growing FN, we investigated whether an increased AMH serum level correlates to other hormonal and/or U/S features of PCOS. Serum AMH has been assayed in 104 women ( 59 symptomatic PCOS, 45 controls) between d 2 and 7 after the last either spontaneous or progestin-induced ( in PCOS) menstrual period. Mean serum AMH level was markedly increased in the PCOS group (47.1 +/- 22.9 vs. 20.8 +/- 11.6 pmol/liter in controls; P < 0.0001), an increase in the same order of magnitude as the one of the FN in the 2- to 5-mm range at U/S (12.8 +/- 8.3 vs. 4.8 +/- 1.9; P < 0.0001, respectively). The ratio AMH/FN was similar between the two groups (4.8 +/- 3.4 vs. 4.8 +/- 2.9; P = 0.55). By simple regression, both in PCOS and controls, the AMH level was positively related to the 2- to 5-mm FN at U/S (P < 0.0001 and P < 0.03, respectively), but not to the 6- to 9-mm FN, and was negatively correlated to the serum FSH level ( P < 0.02 and P < 0.04, respectively). AMH was also positively related to the serum testosterone and androstenedione levels, in PCOS exclusively ( P < 0.0005 and < 0.002, respectively). No relationship was found between AMH and age, serum estradiol, inhibin B, and LH levels in both groups. After multiple regression only the 2- to 5-mm FN remained significantly related to AMH in PCOS whereas testosterone, androstenedione, and FSH were no longer. In conclusion, the assay of the serum AMH may represent an important breakthrough in the diagnosis and in the understanding of PCOS. Our data suggest that the increase of AMH serum level in PCOS is the consequence of the androgen-induced excess in small antral FN and that each follicle produces a normal amount of AMH. We hypothesize that an increased AMH tone within the cohort could be involved in the follicular arrest of PCOS, by interacting negatively with FSH at the time of selection.
引用
收藏
页码:5957 / 5962
页数:6
相关论文
共 50 条
  • [1] Elevated serum level of anti-mullerian hormone (AMH) in polycystic ovary syndrome (PCOS): Relationship to the ovarian follicle excess and to the serum FSH and to the follicular arrest.
    Dewailly, D
    Pigny, P
    Decanter, C
    Robert, Y
    FERTILITY AND STERILITY, 2003, 80 : S276 - S276
  • [2] Elevated serum level of anti-Mullerian hormone in polycystic ovary syndrome: relationship to the ovarian follicle excess and to the serum FSH and androgen level
    Pigny, P.
    Dewailly, D.
    Merlen, E.
    Robert, Y.
    Decanter, C.
    HUMAN REPRODUCTION, 2003, 18 : 25 - 26
  • [3] The relationship between serum anti-Mullerian hormone levels and the follicular arrest for women with polycystic ovary syndrome
    Li, Jian
    Li, Rong
    Yu, Hua
    Zhao, Shuyun
    Yu, Yang
    Qiao, Jie
    SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2015, 61 (02) : 103 - 109
  • [4] Elevated serum anti-Mullerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features
    Pawelczak, Melissa
    Kenigsberg, Lisa
    Milla, Sarah
    Liu, Ying-Hua
    Shah, Bina
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (9-10): : 983 - 989
  • [5] Is the anti-Mullerian hormone (AMH) involved in the follicular arrest of the polycystic ovary syndrome (PCOS)?
    Jonard, S
    Decanter, C
    Pigny, P
    Dewailly, D
    FERTILITY AND STERILITY, 2005, 84 : S150 - S151
  • [6] The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study
    Homburg, R.
    Ray, A.
    Bhide, P.
    Gudi, A.
    Shah, A.
    Timms, P.
    Grayson, K.
    HUMAN REPRODUCTION, 2013, 28 (04) : 1077 - 1083
  • [7] Anti-Mullerian hormone in patients with polycystic ovary syndrome
    Chebotnikova, T.
    Ilyin, A.
    Melnichenko, G.
    Chernukha, G.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2012, 34 (01): : 140 - 140
  • [8] Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome
    Pigny, P
    Jonard, S
    Robert, Y
    Dewailly, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03): : 941 - 945
  • [9] Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome
    Li, Lin
    Chen, Xiaoli
    Mo, Yaqin
    Chen, Yaxiao
    Wenig, Meiying
    Yang, Dongzi
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (17-18) : 519 - 524
  • [10] Anti-mullerian hormone and polycystic ovary syndrome
    Lebkowska, Agnieszka
    Kowalska, Irina
    ENDOKRYNOLOGIA POLSKA, 2017, 68 (01) : 79 - 83